Dogwood Therapeutics Quote - DWTX

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.51

Bid

2.41

Offer

2.65

Volume

22,225

2.42 Day's Range 2.60

1.62 52 Week Range 5.29

Previous Close

2.49

Open

2.49

Last Trade

2.63

Last Trade Time

08:26:42

Average Volume (3m)

83,527

Financial Volume

US$ 55,316

VWAP

2.4889

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.46	-15.4882154882	2.97	2.9999	2.48	24267	2.72542161	CS
4	-0.01	-0.396825396825	2.52	2.9999	2.29	24920	2.58268801	CS
12	0.01	0.4	2.5	5.29	1.62	83527	3.5448633	CS
26	-1.04	-29.2957746479	3.55	5.29	1.62	85305	3.51789516	CS
52	-1.04	-29.2957746479	3.55	5.29	1.62	85305	3.51789516	CS
156	-1.04	-29.2957746479	3.55	5.29	1.62	85305	3.51789516	CS
260	-1.04	-29.2957746479	3.55	5.29	1.62	85305	3.51789516	CS

DWTX - Frequently Asked Questions (FAQ)

What is the current Dogwood Therapeutics share price?

The current share price of Dogwood Therapeutics is US$ 2.51

What is the 1 year trading range for Dogwood Therapeutics share price?

Dogwood Therapeutics has traded in the range of US$ 1.62 to US$ 5.29 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CHEKCheck Cap Ltd	US$ 1.73 (49.78%)	4.4M
TGLTreasure Global Inc	US$ 0.2731 (44.12%)	5.76M
MKZRMackenzie Realty Capital Inc	US$ 2.34 (29.28%)	16.45k
IPDNProfessional Diversity Network Inc	US$ 0.737 (27.66%)	3.9M
MGOLMGO Global Inc	US$ 0.7336 (24.13%)	4.77M
HSDTHelius Medical Technologies Inc	US$ 0.6339 (-9.75%)	4.44k
PTPIPetros Pharmaceuticals Inc	US$ 0.4262 (-8.83%)	145.38k
NITON2OFF Inc	US$ 0.97955 (-8.45%)	2.59M
ALCEAlternus Clean Energy Inc	US$ 0.9221 (-7.77%)	79.36k
EJHE Home Household Service Holdings Ltd	US$ 0.74 (-7.58%)	808k
TGLTreasure Global Inc	US$ 0.2731 (44.12%)	5.76M
IVPInspire Veterinary Partners Inc	US$ 0.2499 (21.19%)	5.52M
CSXCSX Corporation	US$ 32.16 (0.00%)	4.95M
MGOLMGO Global Inc	US$ 0.7336 (24.13%)	4.77M
SVMHSRIVARU Holding Ltd	US$ 0.0584 (-2.67%)	4.62M